Natural products industry companies share overviews on the latest science on their branded ingredients to support wellbeing.

WASHINGTON -- A small implant delivering electrical stimulation to the vagus nerve outperformed a sham treatment in relieving ...

Treatment with pimicotinib achieved a 54% objective response rate at 25 weeks vs 3.2% with placebo in patients with TGCT, ...

Sodium oxybate (Xyrem), a drug approved to treat people with narcolepsy, provided temporary relief for laryngeal dystonia ...

Vitamin D supplementation may help manage hypertension, particularly in older adults with overweight or obesity, a new study ...

Mass Eye and Ear researchers have led a clinical trial of a drug that mimics the effects of alcohol in more than 100 patients ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...

Ciprofol was superior to propofol in inducing anesthesia for colonoscopy as it resulted in lower injection pain and blood pressure reduction.

KarXT - Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new ...

The MANEUVER study met the primary endpoint with an objective response rate (ORR) at week 25 of 54.0% compared with 3.2% for placebo (p- Statistically significant ...

Monthly 140 mg erenumab injections are a safe and effective treatment for patients with nonopioid chronic migraine and medication overuse headaches.